Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,360 | -7,642 | -23,167 | -17,385 | -11,722 |
| Depreciation Amortization | -67 | -56 | 214 | 294 | 281 |
| Other Working Capital | 105 | 97 | 62 | 131 | -485 |
| Other Operating Activity | 1,910 | 901 | 2,099 | 1,641 | 1,211 |
| Operating Cash Flow | $-14,412 | $-6,700 | $-20,792 | $-15,319 | $-10,715 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -523 | -34 | -1,110 | -993 | -905 |
| Purchase Of Investment | -59,255 | -35,936 | -119,244 | -72,995 | -16,412 |
| Sale Of Investment | 62,896 | 36,946 | 36,450 | 0 | N/A |
| Investing Cash Flow | $3,118 | $976 | $-83,904 | $-73,988 | $-17,317 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 184 | 4 | 77,913 | 77,908 | 78,995 |
| Financing Cash Flow | $184 | $4 | $77,913 | $77,908 | $78,995 |
| Exchange Rate Effect | -41 | 8 | -81 | -53 | -36 |
| Beginning Cash Position | 24,182 | 24,182 | 51,046 | 51,046 | 51,046 |
| End Cash Position | 13,031 | 18,470 | 24,182 | 39,594 | 101,973 |
| Net Cash Flow | $-11,151 | $-5,712 | $-26,864 | $-11,452 | $50,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,412 | -6,700 | -20,792 | -15,319 | -10,715 |
| Capital Expenditure | -523 | -34 | -1,120 | -1,003 | -915 |
| Free Cash Flow | -14,935 | -6,734 | -21,912 | -16,322 | -11,630 |